Q3 Sales Fall 4%, Guidance Cut as Core Customer Base Shrinks 8%
USNA sits 18% above its 52-week low of $12.57.
Summary
USANA posted Q3 net sales of $206 million, down 4% from $214 million, with a net loss of $(5.6) million and diluted EPS of $(0.30). Adjusted EBITDA fell 13% to $12.1 million. The core problem is the direct-selling base: Core Nutritional active customers dropped 8% to 356,000, and the segment's sales fell 3% to $171 million. Management cut FY2026 guidance to net sales approaching $900 million and Adjusted EBITDA of $77 million, down from $910 million and $80.5 million, citing weaker Rise Wellness and heavier Hiya marketing spend. The bright spot is Hiya, where active monthly subscribers rose 18% sequentially to 195,500 and sales grew 2% to $32 million. The company also corrected its Q2 Adjusted EBITDA downward by $6.2 million for a goodwill-impairment add-back error, which lowers the prior guidance baseline. Balance sheet is solid: $179 million cash, zero debt, $36 million free cash flow year-to-date. The earnings call is November 4 at 11:00 AM ET.
At the time of this announcement, USNA was trading at $14.87 on NYSE in the Life Sciences sector, with a market capitalization of approximately $274.7M. The 52-week trading range was $12.57 to $23.59. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: BusinessWire.